Renal function, inflammation and bone metabolism in rheumatoid arthritis before menopause

被引:0
作者
Nascimento, Francisco Carlos [1 ]
Leitao de Azevedo, Mario Newton [1 ,2 ]
Saldarriaga Rivera, Lina Maria [3 ]
Mendonca de Carvalho, Laura Maria [4 ]
Rios Gomes Bica, Blanca Elena [1 ,2 ]
机构
[1] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Reumatol, BR-21941 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Fac Med, BR-21941 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil
[4] Univ Fed Rio de Janeiro, Fac Med, Reumatol, BR-21941 Rio De Janeiro, Brazil
来源
REVISTA CUBANA DE REUMATOLOGIA | 2015年 / 17卷 / 03期
关键词
rheumatoid arthritis; bone metabolism; bone mineral density;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: rheumatoid arthritis depends on inflammatory factors such as receptor activator of nuclear factor kappa B Ligand /Osteoprotegerin, essential for bone metabolism and thus, has a great propensity for developing low bone mass. Objectives: to evaluate the influence of renal function and inflammation in bone mass of rheumatoid arthritis patients positive before menopause. Methods: 50 women, 26 with rheumatoid arthritis and 24 healthy control group completed the study. Results: we investigated patients 24 to 49 years. The results demonstrate significant increases in leukocytes, rheumatoid factor, erythrocyte sedimentation, the pyruvic transaminase, and a tendency to increased gamma glutamyl transpeptidase in the rheumatoid arthritis group. Also differences were found with increased levels of sodium and chlorine in these groups compared to controls. A significant change from the urinary pH, more acid in patients with rheumatoid arthritis. There was found no difference with regard to abnormal elements, including for the presence of proteinuria between groups. Patients with rheumatoid arthritis has decreased clearance, but without significant difference compared to the control group. Conclusion: the presence of inflammation is the main reason for developing low bone mass in patients with rheumatoid arthritis.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 14 条
  • [1] 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
    Aletaha, Daniel
    Neogi, Tuhina
    Silman, Alan J.
    Funovits, Julia
    Felson, David T.
    Bingham, Clifton O., III
    Birnbaum, Neal S.
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Cohen, Marc D.
    Combe, Bernard
    Costenbader, Karen H.
    Dougados, Maxime
    Emery, Paul
    Ferraccioli, Gianfranco
    Hazes, Johanna M. W.
    Hobbs, Kathryn
    Huizinga, Tom W. J.
    Kavanaugh, Arthur
    Kay, Jonathan
    Kvien, Tore K.
    Laing, Timothy
    Mease, Philip
    Menard, Henri A.
    Moreland, Larry W.
    Naden, Raymond L.
    Pincus, Theodore
    Smolen, Josef S.
    Stanislawska-Biernat, Ewa
    Symmons, Deborah
    Tak, Paul P.
    Upchurch, Katherine S.
    Vencovsky, Jiri
    Wolfe, Frederick
    Hawker, Gillian
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2569 - 2581
  • [2] [Anonymous], 1999, J PHARM EXP THERAP, V289, P735
  • [3] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [4] Azevedo MNL, 2009, J NATL MED ASSOC, V101, P788
  • [5] Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
    Bolon, B
    Shalhoub, V
    Kostenuik, PJ
    Campagnuolo, G
    Morony, S
    Boyle, WJ
    Zack, D
    Feige, U
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3121 - 3135
  • [6] Does active treatment of rheumatoid arthritis limit disease-associated bone loss?
    Dolan, AL
    Moniz, C
    Abraha, H
    Pitt, P
    [J]. RHEUMATOLOGY, 2002, 41 (09) : 1047 - 1051
  • [7] Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
    Grahnemo, Louise
    Jochems, Caroline
    Andersson, Annica
    Engdahl, Cecilia
    Ohlsson, Claes
    Islander, Ulrika
    Carlsten, Hans
    [J]. JOURNAL OF ENDOCRINOLOGY, 2015, 224 (01) : 97 - 108
  • [8] Effects of rheumatoid arthritis on bone
    Haugeberg, G
    Orstavik, RE
    Kvien, TK
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) : 469 - 475
  • [9] Measurement precision of body composition variables using the Lunar DPX-L densitometer
    Kiebzak, GM
    Leamy, LJ
    Pierson, LM
    Nord, RH
    Zhang, ZY
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2000, 3 (01) : 35 - 41
  • [10] RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis
    Li, Susan
    Miller, Christine H.
    Giannopoulou, Eugenia
    Hu, Xiaoyu
    Ivashkiv, Lionel B.
    Zhao, Baohong
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (11) : 5057 - 5073